Proton radiation study for tougher meningioma tumors
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a type of radiation (protons) for brain tumors called atypical or anaplastic meningiomas that need radiotherapy. It may help by aiming radiation more precisely while also learning the safest and most effective dose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your pathology (biopsy/surgery sample) confirms an atypical (grade II) or anaplastic (grade III) meningioma
- You need radiation therapy as part of your treatment plan
- You can have an MRI (scan with contrast) and also a PET scan for tumor mapping—your metal/pacemaker setup must be MRI-safe
- Your general health is able to take part: Karnofsky score at least 60 and ECOG 2 or less
- If you could become pregnant (or if you’re male), you can use reliable birth control; you must not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan to find active tumor areas and then delivers a stronger dose of radiation to those spots. It is for people with aggressive or returning meningiomas who have not had brain radiation before.
This study compares different radiation methods for treating a slow-growing, non-cancerous brain tumor at the base of the skull. It aims to see which approach best protects memory and thinking abilities.
This study tests a type of focused radiation therapy (called stereotactic radiosurgery) given after surgery for certain meningiomas. The goal is to see if this treatment helps prevent the tumor from coming back, and to check its safety.
This trial tests a radiation plan that gives treatment in fewer, larger “fractions” using proton beams (or sometimes photon beams) for certain non-cancer brain tumor types. It aims to see how well this approach works while keeping side effects manageable.
This study tests whether modern radiation methods—possibly including proton therapy—can treat intracranial meningioma while better protecting thinking and memory. It will look at imaging results and changes in neurocognitive (thinking/memory) function over time.
This trial studies whether radiation given after complete surgery can reduce regrowth of atypical (grade II) meningioma in certain people. It is mainly for tumors that did not involve the brain’s venous sinus and for patients who can safely have follow-up brain MRI scans.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.